Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Wagner Charles F Jr
Relationship:   EVP & Chief Financial ...
City:   Billerica
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   234,683    

Indirect Shares

   0      
Direct Value   $35,362,044    

Indirect Value

   $0      
Total Shares   234,683      
Total Value   $35,362,044      


Progress Software Corp $4,174,830 Bruker Corp $7,745,187 Vertex Pharmaceuticals Inc $23,442,027 Progress Software Corp $4,174,830 Bruker Corp $7,745,187 Vertex Pharmaceuticals Inc $23,442,027
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Progress Software Corp PRGS EVP Finance & Admin an... 2011-10-14 81,175 0    Premium*  
            Bruker Corp BRKR EVP & Chief Financial ... 2015-03-17 99,925 2012-08-02 0    Premium*  
            Vertex Pharmaceuticals Inc VRTX EVP & Chief Financial ... 2024-02-23 53,583 2019-04-10 0    Premium*  
* Premium Members only  

Records found :    45         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2012-08-02 4 A $0.00 $0 D/D 88,028 88,028 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2013-08-02 4 D $19.93 $143,217 D/D (7,186) 80,842 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2013-08-30 4 A $0.00 $0 D/D 25,726 106,568 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2014-08-02 4 D $22.40 $234,662 D/D (10,476) 96,092 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2014-08-08 4 A $0.00 $0 D/D 25,895 121,987 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2014-08-30 4 D $20.26 $62,036 D/D (3,062) 118,925 0 -
BRKR Bruker Corp EVP & Chief Financial Officer   •       –      –    2015-03-17 4 S $18.97 $360,493 D/D (19,000) 99,925 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2020-07-10 4 AS $291.19 $205,206 D/D (700) 16,126 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-02-03 4 A $0.00 $0 D/D 21,951 38,138 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-02-10 4 D $214.16 $506,488 D/D (2,365) 35,773 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-02-24 4 D $217.57 $119,011 D/D (547) 35,226 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2021-04-30 4 D $217.21 $118,814 D/D (547) 34,679 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-01 4 A $0.00 $0 D/D 25,588 60,379 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-02 4 AS $250.07 $736,206 D/D (2,944) 57,435 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-10 4 D $237.74 $578,659 D/D (2,434) 55,001 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-17 4 D $232.51 $799,602 D/D (3,439) 51,562 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-02-24 4 D $227.86 $498,786 D/D (2,189) 49,373 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-03-17 4 AS $250.13 $793,218 D/D (3,171) 46,202 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-04-01 4 AS $261.42 $683,602 D/D (2,582) 43,620 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-04-29 4 D $276.17 $151,065 D/D (547) 43,073 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2022-05-02 4 AS $254.87 $88,778 D/D (343) 42,730 0 %
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-01 4 A $0.00 $0 D/D 30,026 72,890 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-10 4 D $294.33 $796,751 D/D (2,707) 70,183 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-13 4 D $298.26 $1,488,914 D/D (4,992) 65,191 0 -
VRTX Vertex Pharmaceuticals In... EVP & Chief Financial Officer   •       –      –    2023-02-17 4 D $292.85 $1,098,188 D/D (3,750) 61,441 0 -
  45  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us